Grants and Contributions:
Title:
ARP - Prototype B2B - Side Effects Module
Agreement Number:
982259
Agreement Value:
$50,000.00
Agreement Date:
Nov 22, 2021 - Mar 31, 2022
Description:
The project consists of developing a prototype module related to medication and side effect monitoring for parents of children with ADHD.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G2G 0E3
Reference Number:
172-2021-2022-Q3-982259
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
788551315
Recipient Type:
For-profit organization
Recipient's Operating Name:
Neuro Solutions Group
Recipient's Legal Name:
9367-7292 Québec inc.
Federal Riding Name:
Louis-Hébert
Federal Riding Number:
24044
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211